Figure 4.

Global map of innovative clinical trials representative of the future of regenerative medicine, indicating the proportion using mesenchymal stem cells (MSCs; in red). Numbers denote the total number of novel clinical trials in the region; small circles denote regions with one to three novel clinical trials.

Bubela et al. BMC Medicine 2012 10:133   doi:10.1186/1741-7015-10-133
Download authors' original image